Cargando…

Renal Tubular Glucagon-Like Peptide-1 Receptor Expression Is Increased in Early Sepsis but Reduced in Chronic Kidney Disease and Sepsis-Induced Kidney Injury

Acute kidney injury (AKI) is common in patients with sepsis and causes renal ischemia. Glucagon-like peptide-1 (GLP-1) protects the vascular system and the kidney, and GLP-1 receptor (GLP-1R) is expressed in the kidney. Renal GLP-1R activity is decreased in chronic kidney disease (CKD), but is incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jae Hyun, Kim, Seung Jung, Kwon, Soon Kil, Kim, Hye-Young, Jeon, Hyunjung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929157/ https://www.ncbi.nlm.nih.gov/pubmed/31795376 http://dx.doi.org/10.3390/ijms20236024

Ejemplares similares

Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease
por: Li, Ran, et al.
Publicado: (2022)

Effect of Bicarbonate Supplementation on Renal Function and Nutritional Indices in Predialysis Advanced Chronic Kidney Disease
por: Jeong, Jiwon, et al.
Publicado: (2014)

Sepsis-like histoplasmosis in a kidney transplant patient
por: Fernandes, Ana Raquel, et al.
Publicado: (2018)

Altered Lung Heat Shock Protein-70 Expression and Severity of Sepsis-Induced Acute Lung Injury in a Chronic Kidney Disease Rat Model
por: Cho, Jun-Yeun, et al.
Publicado: (2023)

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease
por: Lin, Yuan, et al.
Publicado: (2023)

Glucagon Reduces Neutrophil Migration and Increases Susceptibility to Sepsis in Diabetic Mice
por: Insuela, Daniella Bianchi Reis, et al.
Publicado: (2021)

DPP-4 inhibition enhanced renal tubular and myocardial GLP-1 receptor expression decreased in CKD with myocardial infarction
por: Kim, Seung Jung, et al.
Publicado: (2019)

Is acute kidney injury in the early phase of sepsis a sign of metabolic downregulation in tubular epithelial cells?
por: Jin, K, et al.
Publicado: (2015)

Role of kidney injury in sepsis
por: Doi, Kent
Publicado: (2016)

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
por: Michos, Erin D., et al.
Publicado: (2023)

From Surviving Sepsis to Surviving Sepsis-Associated Acute Kidney Injury: Focusing on Risk Stratification of Acute Kidney Injury / Acute Kidney Disease After Sepsis
por: Kothari, Niraj R., et al.
Publicado: (2021)

Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
por: Kim, Min Kyung, et al.
Publicado: (2021)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Renal scattered tubular-like cells confer protective effects in the stenotic murine kidney mediated by release of extracellular vesicles
por: Zou, Xiangyu, et al.
Publicado: (2018)

Sepsis is associated with mitochondrial DNA damage and a reduced mitochondrial mass in the kidney of patients with sepsis-AKI
por: van der Slikke, Elisabeth C., et al.
Publicado: (2021)

Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Sepsis-induced acute kidney injury
por: Majumdar, Arghya
Publicado: (2010)

Kidney histopathology in lethal human sepsis
por: Aslan, Adnan, et al.
Publicado: (2018)

Trajectory of Kidney Function: The Canary in Sepsis
por: Bhatraju, Pavan K., et al.
Publicado: (2020)

Kidney Injury in Sepsis: Fuel to the Fire
por: Chacko, Binila
Publicado: (2020)

Sepsis-Associated Acute Kidney Disease
por: Peerapornratana, Sadudee, et al.
Publicado: (2020)

In Reply to ‘Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?’
por: Leehey, David J.
Publicado: (2021)

Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury
por: Matejovic, Martin, et al.
Publicado: (2017)

Application of Porcine Kidney-Derived Extracellular Matrix as Coating, Hydrogel, and Scaffold Material for Renal Proximal Tubular Epithelial Cell
por: Lee, Eun Hye, et al.
Publicado: (2022)

Timing of Initiation of Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
por: Agapito Fonseca, José, et al.
Publicado: (2020)

Metabolomics Analysis of the Renal Cortex in Rats With Acute Kidney Injury Induced by Sepsis
por: Ping, Feng, et al.
Publicado: (2019)

Postprandial Glucose, Insulin, and Glucagon-Like Peptide-1 Responses in Healthy Adults after Consumption of Chocolate-Products
por: Choi, Yunjung, et al.
Publicado: (2020)

Renal tubular peroxisomes are dispensable for normal kidney function
por: Ansermet, Camille, et al.
Publicado: (2022)

Renal Cell Carcinoma in a Right Malrotated Kidney
por: Lim, Tae Joon, et al.
Publicado: (2011)

Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation
por: Shou, Di-Wen, et al.
Publicado: (2023)

Sepsis-Associated Acute Kidney Disease and Long-term Kidney Outcomes
por: Flannery, Alexander H., et al.
Publicado: (2021)

Acute kidney injury in sepsis: transient or intrinsic?
por: Jörres, Achim
Publicado: (2013)

Biomarkers of Sepsis-Induced Acute Kidney Injury
por: Wang, Kaifei, et al.
Publicado: (2018)

Metabolomics Analysis of the Development of Sepsis and Potential Biomarkers of Sepsis-Induced Acute Kidney Injury
por: Ping, Feng, et al.
Publicado: (2021)

Acute Kidney Injury in Patients with Sepsis and Septic Shock: Risk Factors and Clinical Outcomes
por: Suh, Sang Heon, et al.
Publicado: (2013)

The Effect of Superoxide Dismutase on Inhibition of Acute Kidney Injury Induced by Sepsis Based on Kidney Tissue Histology and Murine Sepsis Score
por: Ismy, Jufitriani, et al.
Publicado: (2021)

Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial
por: Gómez, Hernando, et al.
Publicado: (2023)

Review of glucagon‐like peptide‐1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects
por: Sloan, Lance A.
Publicado: (2019)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease
por: Kim, Sun Moon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rvqe1brqssktvd4jgork6k4jue